Klinkhammer-Schalke M - Search Results

1

Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma.

Meyer S, Buser L, Haferkamp S, Berneburg M, Maisch T, Klinkhammer-Schalke M, Pauer A, Vogt T, Garbe C. Meyer S, et al. Eur J Cancer. 2023 Mar;182:77-86. doi: 10.1016/j.ejca.2023.01.002. Epub 2023 Jan 7. Eur J Cancer. 2023. PMID: 36753835 Free article.

2

Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM^® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy.

Staubach P, Scharl A, Ignatov A, Ortmann O, Inwald EC, Hildebrandt T, Gerken M, Klinkhammer-Schalke M, Scharl S, Papathemelis T. Staubach P, et al. J Cancer Res Clin Oncol. 2021 Jun;147(6):1813-1823. doi: 10.1007/s00432-020-03461-x. Epub 2020 Nov 23. J Cancer Res Clin Oncol. 2021. PMID: 33230583

3

[Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules].

Gebauer A, Barlag H, Wesselmann S, Biedenweg L, Weitmann K, Klinkhammer-Schalke M, Hoffmann W. Gebauer A, et al. Gesundheitswesen. 2020 Sep;82(8-09):710-715. doi: 10.1055/a-1010-5426. Epub 2019 Dec 16. Gesundheitswesen. 2020. PMID: 31842241 German.

4

The Impact of the COVID-19 Pandemic on Cancer Incidence and Treatment by Cancer Stage in Bavaria, Germany.

Voigtländer S, Hakimhashemi A, Inwald EC, Ortmann O, Gerken M, Klug SJ, Klinkhammer-Schalke M, Meyer M, Müller-Nordhorn J. Voigtländer S, et al. Dtsch Arztebl Int. 2021 Oct 1;118(39):660-661. doi: 10.3238/arztebl.m2021.0329. Dtsch Arztebl Int. 2021. PMID: 34919047 Free PMC article. No abstract available.

5

Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT).

Bolm L, Zemskov S, Zeller M, Baba T, Roldan J, Harrison JM, Petruch N, Sato H, Petrova E, Lapshyn H, Braun R, Honselmann KC, Hummel R, Dronov O, Kirichenko AV, Klinkhammer-Schalke M, Kleihues-van Tol K, Zeissig SR, Rades D, Keck T, Fernandez-Del Castillo C, Wellner UF, Wegner RE. Bolm L, et al. Cancers (Basel). 2022 Feb 9;14(4):868. doi: 10.3390/cancers14040868. Cancers (Basel). 2022. PMID: 35205616 Free PMC article.

6

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.

Fante MA, Felsenstein M, Mayer S, Gerken M, Klinkhammer-Schalke M, Herr W, Vogelhuber M, Reichle A, Heudobler D. Fante MA, et al. Front Oncol. 2022 May 10;12:852987. doi: 10.3389/fonc.2022.852987. eCollection 2022. Front Oncol. 2022. PMID: 35619924 Free PMC article.

7

[Changes in therapy for breast cancer patients as a result of mammography screening. An analysis of Bavarian cancer registry data from 2000 to 2008].

Schrodi S, Braisch U, Schenkirsch G, Maisel T, Petsch S, Hölzel D, Klinkhammer-Schalke M, Mäder U, Schuller L, Heywang-Köbrunner SH, Meyer M, Engel J. Schrodi S, et al. Gesundheitswesen. 2013 Oct;75(10):632-42. doi: 10.1055/s-0032-1331732. Epub 2013 Feb 12. Gesundheitswesen. 2013. PMID: 23404360 German.

8

[Methodology and Attribution Success of a Data Linkage of Clinical Registry Data with Health Insurance Data].

Bobeth C, Tol KK, Rößler M, Bierbaum V, Gerken M, Günster C, Dröge P, Ruhnke T, Klinkhammer-Schalke M, Schmitt J, Schoffer O. Bobeth C, et al. Gesundheitswesen. 2023 Mar;85(S 02):S154-S161. doi: 10.1055/a-1984-0085. Epub 2023 Mar 20. Gesundheitswesen. 2023. PMID: 36940697 Free article. German.

9

[Diagnosis and therapy of illness-related quality of life in breast cancer patients. Protocol of a randomized clinical trial at the Regensburg Tumour Centre].

Koller M, Klinkhammer-Schalke M, Ehret C, Steinger B, Ernst B, Hofstädter F, Lorenz W; Mitglieder des Qualitätszitkels; Advisory Boards. Koller M, et al. Z Arztl Fortbild Qualitatssich. 2006;100(3):175-82. Z Arztl Fortbild Qualitatssich. 2006. PMID: 16768082 German.

10

[Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg].

Klotz T, Mathers MJ, Gerken M, Klinkhammer-Schalke M, Hofstädter F. Klotz T, et al. Urologe A. 2010 Dec;49(12):1503-7. doi: 10.1007/s00120-010-2425-2. Urologe A. 2010. PMID: 20945060 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters